Review



mucin 16 ca125  (R&D Systems)


Bioz Verified Symbol R&D Systems is a verified supplier
Bioz Manufacturer Symbol R&D Systems manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 93
      Buy from Supplier

    Structured Review

    R&D Systems mucin 16 ca125
    FIGURE 2 | IPF stables showed decrease in <t>CA125</t> and POSTN levels 3 months post-antifibrotic treatment. Serum CA125 and POSTN levels in progressive (red) and stable (blue) at 0, 3, 6 and 12 months post-antifibrotic treatment in the (a and d) Cohort 1, (b and e) Cohort 2 and (c and f) Combined cohort. Box represents interquartile range with median and whiskers represent range. *p < 0.05, **p < 0.01, ***p < 0.001.
    Mucin 16 Ca125, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 13 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mucin+16+ca125/pm39919729-44-42-53?v=R%26D+Systems
    Average 93 stars, based on 13 article reviews
    mucin 16 ca125 - by Bioz Stars, 2026-08
    93/100 stars

    Images

    1) Product Images from "Pre-Treatment MMP7 Predicts Progressive Idiopathic Pulmonary Fibrosis in Antifibrotic Treated Patients."

    Article Title: Pre-Treatment MMP7 Predicts Progressive Idiopathic Pulmonary Fibrosis in Antifibrotic Treated Patients.

    Journal: Respirology (Carlton, Vic.)

    doi: 10.1111/resp.14894

    FIGURE 2 | IPF stables showed decrease in CA125 and POSTN levels 3 months post-antifibrotic treatment. Serum CA125 and POSTN levels in progressive (red) and stable (blue) at 0, 3, 6 and 12 months post-antifibrotic treatment in the (a and d) Cohort 1, (b and e) Cohort 2 and (c and f) Combined cohort. Box represents interquartile range with median and whiskers represent range. *p < 0.05, **p < 0.01, ***p < 0.001.
    Figure Legend Snippet: FIGURE 2 | IPF stables showed decrease in CA125 and POSTN levels 3 months post-antifibrotic treatment. Serum CA125 and POSTN levels in progressive (red) and stable (blue) at 0, 3, 6 and 12 months post-antifibrotic treatment in the (a and d) Cohort 1, (b and e) Cohort 2 and (c and f) Combined cohort. Box represents interquartile range with median and whiskers represent range. *p < 0.05, **p < 0.01, ***p < 0.001.

    Techniques Used:



    Similar Products

    ca125 (mucin- 16) human procartaplex simplex kit  (Thermo Fisher)
    90
    Thermo Fisher ca125 (mucin- 16) human procartaplex simplex kit
    Ca125 (Mucin 16) Human Procartaplex Simplex Kit, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mucin+16+ca125/pm35975985-378-61-54?v=Thermo+Fisher
    Average 90 stars, based on 1 article reviews
    ca125 (mucin- 16) human procartaplex simplex kit - by Bioz Stars, 2026-08
    90/100 stars
    		  Buy from Supplier
    ca125  (OriGene)
    90
    OriGene ca125
    Ca125, supplied by OriGene, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mucin+16+ca125/pmc12150475-102-25-60?v=OriGene
    Average 90 stars, based on 1 article reviews
    ca125 - by Bioz Stars, 2026-08
    90/100 stars
    		  Buy from Supplier
    ca125  (Santa Cruz Biotechnology)
    93
    Santa Cruz Biotechnology ca125
    Fig. 6 (a and b) Western blot analysis of oxidative genes. (a) A2780 and (b) ID8 cells were incubated with ZnNP, ZnCl2, SNP (25 μg ml−1), and CisPt (3 µg ml−1; 10 µM) for 24 h. (c–f) Cytotoxicity of ZnNP, ZnCl2, SNP and CisPt on healthy liver and PDTOs obtained from HGSOC patients (Pat A–C). Error bars represent the standard error of the mean (SEM). Groups were considered statistically significant if p < 0.05 (*), p < 0.01 (**) or non-signifi- cant (ns). (g) Hematoxylin & eosin staining and immunohistochemistry (PAT <t>A–C).</t> <t>CA-125</t> (cancer antigen 125), WT1 (Wilms’ tumor 1) and PAX8 (paired box gene 8) are markers of ovarian cancer (all images 40×, bar = 50 µm).
    Ca125, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mucin+16+ca125/pm40099529-156-23-31?v=Santa+Cruz+Biotechnology
    Average 93 stars, based on 1 article reviews
    ca125 - by Bioz Stars, 2026-08
    93/100 stars
    		  Buy from Supplier
    mucin 16 ca125  (R&D Systems)
    93
    R&D Systems mucin 16 ca125
    FIGURE 2 | IPF stables showed decrease in <t>CA125</t> and POSTN levels 3 months post-antifibrotic treatment. Serum CA125 and POSTN levels in progressive (red) and stable (blue) at 0, 3, 6 and 12 months post-antifibrotic treatment in the (a and d) Cohort 1, (b and e) Cohort 2 and (c and f) Combined cohort. Box represents interquartile range with median and whiskers represent range. *p < 0.05, **p < 0.01, ***p < 0.001.
    Mucin 16 Ca125, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mucin+16+ca125/pm39919729-44-42-53?v=R%26D+Systems
    Average 93 stars, based on 1 article reviews
    mucin 16 ca125 - by Bioz Stars, 2026-08
    93/100 stars
    		  Buy from Supplier
    ca125 (mucin- 16) human procartaplex simplex kit (epx010- 12437- 901)  (Thermo Fisher)
    90
    Thermo Fisher ca125 (mucin- 16) human procartaplex simplex kit (epx010- 12437- 901)
    FIGURE 2 | IPF stables showed decrease in <t>CA125</t> and POSTN levels 3 months post-antifibrotic treatment. Serum CA125 and POSTN levels in progressive (red) and stable (blue) at 0, 3, 6 and 12 months post-antifibrotic treatment in the (a and d) Cohort 1, (b and e) Cohort 2 and (c and f) Combined cohort. Box represents interquartile range with median and whiskers represent range. *p < 0.05, **p < 0.01, ***p < 0.001.
    Ca125 (Mucin 16) Human Procartaplex Simplex Kit (Epx010 12437 901), supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mucin+16+ca125/10__7554_slash_elife__79794-378-61-54?v=Thermo+Fisher
    Average 90 stars, based on 1 article reviews
    ca125 (mucin- 16) human procartaplex simplex kit (epx010- 12437- 901) - by Bioz Stars, 2026-08
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    Fig. 6 (a and b) Western blot analysis of oxidative genes. (a) A2780 and (b) ID8 cells were incubated with ZnNP, ZnCl2, SNP (25 μg ml−1), and CisPt (3 µg ml−1; 10 µM) for 24 h. (c–f) Cytotoxicity of ZnNP, ZnCl2, SNP and CisPt on healthy liver and PDTOs obtained from HGSOC patients (Pat A–C). Error bars represent the standard error of the mean (SEM). Groups were considered statistically significant if p < 0.05 (*), p < 0.01 (**) or non-signifi- cant (ns). (g) Hematoxylin & eosin staining and immunohistochemistry (PAT A–C). CA-125 (cancer antigen 125), WT1 (Wilms’ tumor 1) and PAX8 (paired box gene 8) are markers of ovarian cancer (all images 40×, bar = 50 µm).

    Journal: Biomaterials science

    Article Title: Self-targeted nanosystem for enhanced chemodynamic cancer therapy.

    doi: 10.1039/d4bm01683a

    Figure Lengend Snippet: Fig. 6 (a and b) Western blot analysis of oxidative genes. (a) A2780 and (b) ID8 cells were incubated with ZnNP, ZnCl2, SNP (25 μg ml−1), and CisPt (3 µg ml−1; 10 µM) for 24 h. (c–f) Cytotoxicity of ZnNP, ZnCl2, SNP and CisPt on healthy liver and PDTOs obtained from HGSOC patients (Pat A–C). Error bars represent the standard error of the mean (SEM). Groups were considered statistically significant if p < 0.05 (*), p < 0.01 (**) or non-signifi- cant (ns). (g) Hematoxylin & eosin staining and immunohistochemistry (PAT A–C). CA-125 (cancer antigen 125), WT1 (Wilms’ tumor 1) and PAX8 (paired box gene 8) are markers of ovarian cancer (all images 40×, bar = 50 µm).

    Article Snippet: The following antibodies were used to characterize PDTO and parental tumours: PAX8 (catalog no.: 10336-1-AP, dilution 1 : 400, ProteinTech Group, Planegg-Martinsried, Germany), CA125 (catalog no.: sc-52095, dilution 1 : 100, Santa Cruz Biotechnology, Dallas, TX, USA) and WT1 (catalog no.: ab89901, dilution 1 : 300, Abcam, Cambridge, UK).

    Techniques: Western Blot, Incubation, IF-P, Staining, Immunohistochemistry, Wilms Tumor Assay

    FIGURE 2 | IPF stables showed decrease in CA125 and POSTN levels 3 months post-antifibrotic treatment. Serum CA125 and POSTN levels in progressive (red) and stable (blue) at 0, 3, 6 and 12 months post-antifibrotic treatment in the (a and d) Cohort 1, (b and e) Cohort 2 and (c and f) Combined cohort. Box represents interquartile range with median and whiskers represent range. *p < 0.05, **p < 0.01, ***p < 0.001.

    Journal: Respirology (Carlton, Vic.)

    Article Title: Pre-Treatment MMP7 Predicts Progressive Idiopathic Pulmonary Fibrosis in Antifibrotic Treated Patients.

    doi: 10.1111/resp.14894

    Figure Lengend Snippet: FIGURE 2 | IPF stables showed decrease in CA125 and POSTN levels 3 months post-antifibrotic treatment. Serum CA125 and POSTN levels in progressive (red) and stable (blue) at 0, 3, 6 and 12 months post-antifibrotic treatment in the (a and d) Cohort 1, (b and e) Cohort 2 and (c and f) Combined cohort. Box represents interquartile range with median and whiskers represent range. *p < 0.05, **p < 0.01, ***p < 0.001.

    Article Snippet: Serum levels of matrix metalloproteinase- 7 (MMP7), periostin (POSTN), C- X- C motif ligand 13 (CXCL13), intercellular adhesion molecule- 1 (ICAM- 1), osteopontin (OPN), C- C motif ligand 18 (CCL18), surfactant protein- D (SP- D), chitinase- 3- like protein- 1 (CHI3L1) and mucin 16 (CA125) were measured by ELISA using DuoSet ELISA Kits (R&D Systems, MN, USA) according to manufacturer's instruction.

    Techniques: